Baird Cuts Price Target on Regeneron (REGN) as Late Stage Trials Hit Operating Costs - Reiterates Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/14/2026

1. NVDA
2. ORCL
3. USO
4. SPY
5. SRRK
6. DFTX
7. AZN
8. CGEM
9. LYNX
10. SATL

Go back to Baird Cuts Price Target on Regeneron (REGN) as Late Stage Trials Hit Operating Costs - Reiterates Outperform
Regeneron (NASDAQ: REGN) Delayed: 797.93 +16.44 (2.10%)
Previous Close $781.49    52 Week High $592.36 
Open $791.98    52 Week Low $325.35 
Day High $798.84    P/E 209.43 
Day Low $779.45    EPS $3.81 
Volume 234,637